EQUITY RESEARCH MEMO

Epic Medical Research

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)45/100

Epic Medical Research is a US-based clinical research organization (CRO) that specializes in patient-centered clinical trials, primarily serving the digital health sector. Founded in 2015 and headquartered in San Francisco, the company operates a network of research sites across Texas, Oklahoma, Louisiana, Alabama, and Arizona. As a private company, it focuses on rigorous trial execution and advancing healthcare through flexible, decentralized trial models. With no disclosed funding or valuation, Epic Medical Research appears to be a niche CRO leveraging regional site networks to attract digital health sponsors seeking efficient patient recruitment and retention. The CRO market is growing, and Epic's focus on patient-centricity could differentiate it, but its limited geographic footprint and lack of public financial data present challenges to assessing scale and competitive positioning.

Upcoming Catalysts (preview)

  • 2026Expansion into new states or trial site acquisitions60% success
  • 2026-2027Major contract win with a top digital health sponsor50% success
  • 2026-2027Partnership or collaboration with a decentralized trial technology platform40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)